Attached files
| file | filename |
|---|---|
| EX-5.1 - LEGAL OPINION WITH CONSENT - Instadose Pharma Corp. | mikrocoze_ex51.htm |
| EX-3.4 - MASTER MANUFACTURING AGREEMENT - Instadose Pharma Corp. | mikrocoze_ex34.htm |
| EX-3.3 - SUBSCRIPTION AGREEMENT - Instadose Pharma Corp. | mikrocoze_ex33.htm |
| EX-3.2 - BY-LAWS - Instadose Pharma Corp. | mikrocoze_ex32.htm |
| EX-3.1 - ARTICLES OF INCORPORATION - Instadose Pharma Corp. | mikrocoze_ex31.htm |
| S-1 - FORM S-1 - Instadose Pharma Corp. | mikrocoze_s1.htm |
EXHIBIT 23.1
|
|
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Mikrocoze Inc.
As independent registered public accountants, we hereby consent to the use of our report dated February 24, 2017, with respect to the financial statements of Mikrocoze Inc., in its registration statement on Form S-1 relating to the registration of 5,000,000 shares of common stock. We also consent to the reference of our firm under the caption “interests of named experts and counsel” in the registration statement.
/s/ Sadler, Gibb & Associates, LLC
Salt Lake City, UT
February 24, 2017
